Tutorials › Multi-Arm Multi-Stage (MAMS) Designs › Reporting Treatment Estimates After Adaptive Selection

Treatment-Effect Estimation After Selection · Tutorial 290 of 499

Reporting Treatment Estimates After Adaptive Selection

A transparent post-selection report states which arm was selected, how selection was handled, what the interval covers, and which population of adaptive trial paths the result describes.

Advanced 11 min read

What You'll Learn

  • Identify the treatment contrast and selected arm in a post-selection estimate.
  • Distinguish conditional inference for the observed selection path from marginal inference across possible paths.
  • Report the selection rule and the adjustment procedure needed to interpret a point estimate.
  • Describe an uncertainty interval by its method, confidence level, and coverage target.
  • Recognize why selecting the largest noisy estimate can make an unadjusted estimate optimistic.
  • Present sensitivity analyses and diagnostics without treating them as substitutes for a clearly defined primary result.

Why Reporting Must Include the Selection Process

An estimate reported after adaptive arm selection is not fully interpretable on its own. Readers need to know which treatment was selected, how the selection rule used the accumulating data, what treatment effect the estimate targets, and how both the point estimate and its uncertainty account for selection. Otherwise, a favorable estimate can be mistaken for an ordinary estimate from a trial in which the treatment was specified in advance.

For example, a trial may select the active arm with the largest interim benefit and then report that arm’s final estimate. Even if every arm has the same true effect, selecting the largest interim estimate tends to select a positive random error as well as any genuine benefit. The issue is not resolved simply by reporting a standard error or a confidence interval: those quantities must also correspond to an analysis that accounts for the adaptive selection.

Definition: A post-selection treatment estimate is an estimate reported for an arm or contrast chosen through a data-dependent selection rule. A complete report specifies (1) the target treatment effect, (2) the selection rule and observed selection outcome, (3) the point-estimation and selection-adjustment methods, (4) the uncertainty interval and its calibration, and (5) whether the interpretation is conditional on the observed selection path or marginal over possible paths.

For notation, let \(\theta_k\) denote the treatment effect for active arm \(k\) relative to the common control, with the effect scale and direction stated in context. Let \(J\) be the selected arm, determined by a prespecified rule \(g\) applied to interim and, if relevant, later trial data. The reported contrast is then for arm \(J\), not an arm that can be treated as if it had been named before the data were observed.

Conditional and Marginal Interpretations

A conditional analysis describes uncertainty given a specified selection event or path—for example, given that arm B was retained at the interim analysis and selected at the end. A marginal analysis describes uncertainty across repeated trials in which the adaptive rule is applied and the selected arm or path may differ. These are distinct inferential targets. A conditional interval should not be presented as if it covered across all possible trial paths, and a marginal interval should not be described as conditional on the particular path observed.

The phrase “conditional on selection” needs enough detail to identify the conditioning event. It might mean conditioning only on the final arm being selected, or on the entire sequence of interim decisions. Those events need not lead to the same distribution. A report should name the event actually used in the adjustment and interval calibration.

The underlying treatment effect may be a fixed arm-specific contrast, such as \(\theta_B\). The fact that the arm index \(J\) is random does not make \(\theta_B\) random; rather, which fixed parameter is reported can vary across repeated trials. This distinction helps prevent ambiguity between estimating the effect of the arm selected in this trial and describing average performance of the selection strategy over repeated trials.

Reporting principle: Name the selected arm and the target contrast, then state whether inference is conditional on the observed selection event or marginal over the trial’s adaptive selection process. The point estimate, interval, and interpretation must refer to compatible targets.

Why Naive Selected Estimates Tend to Be Optimistic

A short calculation illustrates the source of selection bias. Suppose two arms have the same true effect \(\theta\), and their interim estimates are \(X_1=\theta+\epsilon_1\) and \(X_2=\theta+\epsilon_2\), where the errors are independent and each has distribution \(N(0,\sigma^2)\). If the arm with the larger estimate is selected, its interim estimate is \(\theta+\max(\epsilon_1,\epsilon_2)\).

The maximum can be written as \((\epsilon_1+\epsilon_2+|\epsilon_1-\epsilon_2|)/2\). The first two errors have mean zero. Since \(\epsilon_1-\epsilon_2\sim N(0,2\sigma^2)\), its expected absolute value is \(2\sigma/\sqrt{\pi}\). Therefore:

$$ E\{\max(X_1,X_2)\} = \theta+\frac{1}{2}E|\epsilon_1-\epsilon_2| = \theta+\frac{\sigma}{\sqrt{\pi}}. $$

Thus, even when the true effects are equal, the selected interim estimate exceeds the common effect on average. Real MAMS designs can involve multiple stages, shared controls, different allocation ratios, and more complex rules; this simple calculation is an illustration, not a correction formula for those settings. It explains why a report should say how the actual selection process was handled.

What a Complete Report Needs to Say

A concise report can still be technically complete. It should give enough information for a reader to identify the estimand, reconstruct the decision context, and understand the source and meaning of uncertainty. In particular, report:

  • Selection rule: which interim or final data were used, the decision criterion, and any arm-dropping or stopping decisions relevant to the reported arm.
  • Observed selection: the arm selected and, where useful, the realized path—for example, which arms were dropped at interim.
  • Effect scale and direction: such as a treatment-minus-control mean difference in points or a treatment-to-control risk ratio. State which direction favors treatment.
  • Point estimate and adjustment: give the unadjusted estimate if it helps, but clearly distinguish it from the reported selection-adjusted estimate. Name the adjustment method and the main model or resampling assumptions.
  • Uncertainty interval: state the confidence level, method, and whether its coverage is conditional on a stated selection event or marginal over paths.
  • Diagnostics and sensitivity: summarize checks that bear on the selection rule, outcome model, or adjustment method and indicate whether conclusions materially change under reasonable alternatives.

A numerical interval alone does not communicate its calibration. For example, “95% interval” is incomplete unless it is clear whether the interval is an ordinary unadjusted interval, a selection-adjusted conditional interval, or a marginal interval. The usual repeated-sampling interpretation applies only under the assumptions and calibration method stated for that interval; it is not a probability statement about the fixed treatment effect after the data have been observed.

Worked Example: Reporting a Continuous Outcome Estimate

Hypothetical trial. A trial compares three active treatments with a common control on a symptom score, where a larger score reduction is better. At interim, the two arms with the largest estimated reductions are retained; arm A is later selected for reporting. The raw treatment-minus-control contrast in reduction is 5.4 points. A selection-aware parametric bootstrap estimates that the raw contrast is optimistic by 1.1 points, giving an adjusted estimate of \(5.4-1.1=4.3\) points. The same prespecified bootstrap procedure, which reproduces the trial’s selection rule and targets inference conditional on the observed path, gives a 95% interval from 1.8 to 6.7 points.

Assumptions and checks. This illustration assumes the outcome model used by the parametric bootstrap adequately represents the continuous endpoint and the dependence induced by the shared control. It also assumes that the bootstrap reproduces the actual interim timing, allocation, dropping decisions, and final selection rule. The reported conditional interval is justified only if the procedure has suitable conditional calibration for the stated path; the numbers alone do not establish that calibration. Model fit and the simulated frequency of the observed path should therefore be checked.

Report. “Arm A was selected under the prespecified interim retention and final selection rule. Its selection-adjusted estimated mean improvement over control was 4.3 symptom-score points. A 95% selection-aware parametric-bootstrap interval was 1.8 to 6.7 points, calibrated conditional on the observed selection path. The model-based correction assumes the fitted outcome model and the implemented selection rule adequately represent the trial.”

Because larger reductions favor treatment, the estimate and both interval limits indicate greater improvement for arm A than control on this hypothetical analysis. The interval describes uncertainty for the stated conditional target; it does not say there is a 95% probability that the fixed effect lies between 1.8 and 6.7 points.

Keep the Estimate and Interval on the Same Target

Adjustment and interval construction are related but separate tasks. A correction to a point estimate does not, by itself, provide a valid standard error or confidence interval. Conversely, a selection-aware interval must be centered and interpreted in relation to the estimand for which its calibration was established. If a conditional point estimate is paired with a marginal interval, or an adjusted estimate with an ordinary unadjusted interval, the displayed pair may not support the intended conclusion.

The choice between conditional and marginal inference should follow the scientific question, not which interval is narrower. A conditional analysis can focus on the specific selected arm and observed path, but it depends on the conditioning event and may be less stable when that event is rare. Marginal inference reflects the full adaptive strategy and variation across paths, but may be less directly about the exact path seen in this trial. Neither description is universally preferable.

Worked Example: Explaining Conditional Versus Marginal Results

Hypothetical trial. Three active arms are compared with control. The interim rule drops arms whose standardized interim contrast is below a prespecified threshold; the remaining arm with the largest final contrast is selected. Arm B is selected after arm C was dropped at interim. A selection-aware analysis reports a conditional adjusted mean difference of 2.1 mg/dL, with a 95% conditional interval from \(-0.7\) to 4.9 mg/dL, given this particular selection path. A separate analysis targeting repeated application of the complete adaptive design reports a marginal adjusted estimate of 2.6 mg/dL and a 95% marginal interval from 0.4 to 4.8 mg/dL.

Assumptions and checks. Treat these as hypothetical outputs from procedures separately calibrated for the stated conditional and marginal targets. Both rely on a suitable outcome model and faithful implementation of the interim rule, including the information available at each decision. Calibration should be checked by simulation under plausible parameter values, with conditional coverage assessed for the specified path and marginal coverage assessed over all paths.

The conditional result says that, under its assumptions and conditioning event, arm B’s estimated effect is 2.1 mg/dL and the interval includes effects below and above zero. The marginal result summarizes performance across adaptive repetitions and has an interval above zero. These are not contradictory calculations of one identical target: they answer different questions. A report should choose the target that matches its scientific claim and label it explicitly. It should not report the marginal estimate beside the conditional interval as though the two formed a single inferential result.

Reporting on a Ratio Scale

For ratio measures, it is often useful to perform estimation and interval construction on the log scale, then transform both the estimate and interval limits back to the ratio scale. The report should state the event, numerator, denominator, and direction of benefit. A ratio of 1 represents equal risks; whether values below or above 1 favor treatment depends on the event being analyzed.

Worked Example: Reporting a Selection-Adjusted Risk Ratio

Hypothetical trial. The selected arm is chosen because interim data suggest a lower risk of an adverse event. The unadjusted estimated log risk ratio for selected treatment versus control is \(-0.36\). A selection-adjustment procedure estimates that selection shifted the raw log risk ratio downward by 0.12. The adjusted log risk ratio is therefore \(-0.36-(-0.12)=-0.24\). Suppose a selection-aware procedure gives a 95% interval on the log scale from \(-0.60\) to \(0.12\), calibrated conditional on the observed selection event.

Transform the estimate. Exponentiating gives the adjusted risk ratio:

$$ \widehat{RR}_{\mathrm{adj}}=\exp(-0.24)\approx 0.7866. $$

Transform the limits. Since exponentiation is increasing, exponentiate each endpoint:

$$ \left[\exp(-0.60),\exp(0.12)\right] \approx [0.5488,1.1275]. $$

Assumptions and interpretation. This assumes the adjustment and interval procedure is appropriate for the log-risk-ratio estimand and the stated selection event. The estimated adverse-event risk in the selected arm is about 0.787 times the control risk on this adjusted analysis. The 95% conditional interval includes 1, so it is compatible with lower risk, equal risk, or higher risk for the selected arm under the procedure’s assumptions. It is not evidence that the null is true, nor a 95% probability that the fixed risk ratio lies in this interval.

Report. “Arm [name] was selected under [selection rule]. Its selection-adjusted adverse-event risk ratio versus control was 0.787 (95% selection-aware conditional interval 0.549 to 1.13), conditional on [selection event]. The analysis used [adjustment method] under [key outcome-model assumptions].” Fill in the bracketed details rather than leaving the selection event or method implicit.

Diagnostics, Alternatives, and Limitations

A well-written result does not replace diagnostics. The report should indicate whether the implemented rule matches the protocol and whether the adjustment method was evaluated under conditions resembling the design. Useful checks include comparing the programmed and actual selection pathways, examining model fit and shared-control dependence, assessing the frequency of the observed path in simulation, and evaluating coverage separately for conditional and marginal targets when both are relevant. Large changes under plausible selection-rule or outcome-model alternatives should be disclosed.

The main alternatives are not interchangeable labels. An unadjusted analysis is simple and may describe the observed data, but after data-driven selection its estimate and conventional interval may not have their usual repeated-sampling properties for the selected target. Selection-aware bootstrap or model-based methods can incorporate the adaptive rule, but their conclusions depend on how well the resampling or model represents the design and outcome distribution. Randomization-based approaches rely on the randomization structure and define inference through that design. The report should name the method actually used rather than saying only “corrected for selection.”

Adjustment cannot repair an inaccurately recorded selection rule, unmodeled outcome features, or an unclear estimand. Conditional intervals may be difficult to calibrate for rare paths; marginal results can obscure what is learned about the particular arm selected. Estimates can also be sensitive to the outcome model or to the precise decision boundary. These are reasons to report sensitivity and diagnostics, not reasons to omit the primary estimate.

A Common Reporting Mistake

  • Wrong reasoning: “The selected arm’s final estimate is 4.3 points, and its ordinary 95% interval is 1.8 to 6.7, so selection is already handled because the estimate uses final-stage data.”
  • Correction: Using later data does not automatically remove the consequences of selecting an arm with earlier data. State whether the final analysis accounts for the full selection process, identify the method and its assumptions, and label the interval’s conditional or marginal coverage target. If only an ordinary interval was calculated, report it as such rather than implying selection-aware inference.
Key takeaway: A post-selection result is interpretable only when the treatment contrast, selected arm, selection rule, adjustment method, interval calibration, and conditional or marginal target are stated together. The estimate and interval must address the same target.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

  1. What information is missing from the statement, “The selected treatment effect was 3.2 with a 95% interval from 0.5 to 5.9”?
  2. In the two-arm equal-effect illustration, why does selecting the larger interim estimate produce an average above the true effect?
  3. A conditional interval is calibrated given arm B was selected and arm C was dropped. Can it be described as an interval for performance averaged over all trial paths?
  4. A selection-adjusted risk ratio is 0.80 with a 95% interval from 0.60 to 1.05. What does the inclusion of 1 mean, and what does it not mean?
  5. Name two diagnostics that could reveal a problem with a selection-adjusted analysis.

Solutions. (1) It needs the contrast and units, which arm was selected, the selection rule and observed path, the adjustment and interval methods, and whether inference is conditional or marginal. (2) The selected estimate is the true effect plus the maximum of two errors; the maximum has positive expected value, \(E\{\max(\epsilon_1,\epsilon_2)\}=\sigma/\sqrt{\pi}\). (3) No. It is calibrated for the stated conditioning event, not automatically for the distribution across all possible paths. (4) The interval is compatible with a risk ratio below, equal to, or above 1 under the method’s assumptions. It does not give the probability that the null is true or that the fixed ratio lies in the interval. (5) Examples include checking that the implemented selection rule matches the protocol, examining outcome-model fit, checking simulated coverage for the stated target, and assessing how often the observed path occurs under the fitted model.

Clinical Biostats